APOLLOHOSP
508869Reg. 34 (1) Annual Report.
Dear Sir, Sub : Submission of Updated Annual Report for FY 2025-26 We refer to the Annual Report of the Company for the financial year ended 31 March 2026, which was submitted to the Stock Exchanges...read more
Apollo Hospitals Enterprise Ltd is India's leading integrated healthcare provider, established in 1983 and headquartered in Chennai. The company operates a vast network of over 70 hospitals, 400+ clinics, 4,000+ pharmacies, as well as diagnostic centers across the country, addressing diverse healthcare needs from primary to tertiary care. Apollo offers specialized services in cardiology, cancer care, orthopedics, neurology, and transplants, with centers of excellence dedicated to complex treatments and surgeries.
Reg. 34 (1) Annual Report.
Dear Sir, Sub : Submission of Updated Annual Report for FY 2025-26 We refer to the Annual Report of the Company for the financial year ended 31 March 2026, which was submitted to the Stock Exchanges and circulated to the members of the Company on 1st August 2026. After submission, it has been observed that, while preparing the final layout version of the Annual Report for FY 2025-26, a paragraph was inadvertently omitted from the final artwork due to an editorial oversight. Accordingly, the revised Annual Report is being submitted after incorporating the omitted paragraph. Except for this, there are no factual or material changes to the contents of the Annual Report submitted earlier and this does not have any other impact in the Notice of AGM, Financial Statements, Boards'' Report etc. The updated Annual Report will also be hosted on the Company's website in place of the earlier version. Kindly take on record
Summary Of Proceedings Of AGM And Voting Results
As per annexure enclosed
Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
As per annexure enclosed
Shareholder Meeting / Postal Ballot-Outcome of AGM
As per annexure enclosed
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
as per annexure enclosed
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
As per annexure enclosed
Announcement under Regulation 30 (LODR)-Investor Presentation
As per annexure enclosed
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
As per annexure enclosed
Announcement under Regulation 30 (LODR)-Press Release / Media Release
As per annexure enclosec
Board Meeting Outcome for Outcome Of The Board Meeting
As per annexure enclosed
Outcome Of The Board Meeting - Financial Results
As per annexure enclosed
Notice Published In News Papers - 45Th AGM And Evoting Related Information; Record Date For Payment Of Dividend Etc
as per annexure enclosed
Apollo Hospitals Enterprise Ltd
About
Apollo Hospitals Enterprise Ltd is India's leading integrated healthcare provider, established in 1983 and headquartered in Chennai. The company operates a vast network of over 70 hospitals, 400+ clinics, 4,000+ pharmacies, as well as diagnostic centers across the country, addressing diverse healthcare needs from primary to tertiary care. Apollo offers specialized services in cardiology, cancer care, orthopedics, neurology, and transplants, with centers of excellence dedicated to complex treatments and surgeries.
Leveraging advanced medical technology, strong clinical expertise, and a robust digital healthcare ecosystem, Apollo Hospitals continually invests in innovation through its telemedicine network, digital health platforms, and healthcare education initiatives. Its vertically integrated model enables cross-referral among its facilities, driving synergy and accessibility within one of India's largest healthcare infrastructures.
Business Model & Strategy
Apollo Hospitals earns revenue through a mix of patient care services, pharmacy retail, diagnostics, preventive health programs, and digital health solutions. Core income streams arise from inpatient and outpatient services, major surgical procedures, specialty medicine, and allied services including radiology and pathology. Apollo Pharmacy, the branded retail pharmacy chain, is a significant contributor, with rapid expansion and leadership in organized pharmacy retail.
Strategically, Apollo emphasizes network expansion into tier-II and tier-III cities, acquisition of specialty hospitals, and the development of technology-driven healthcare delivery such as telehealth and app-driven consultation. Growth vectors include value-driven health packages, insurance partnerships, digital health services like Apollo 24/7, and a focus on high-value, complex treatments, enabling recurring engagement and scale across India.
Management Overview
12 MembersMr.PRATAP C REDDY
Executive Director-Chairperson related to PromoterMrs.PREETHA REDDY
Executive DirectorMrs.SUNEETA REDDY
Executive Director-MDKrishnanAkhileswaran
Chief Finance Officer (CFO)Mrs.SHOBANA KAMINENI
Non-Executive - Non Independent DirectorMrs.SANGITA REDDY
Executive DirectorMr.PUDUGRAMAM MURALI DORAISWAMY
Non-Executive - Independent DirectorMr.MANDAVILLI BHASKARA NAGESWARA RAO
Non-Executive - Independent DirectorMrs.VELAGAPUDI KAVITHA V DUTT
Non-Executive - Independent DirectorMr.SOM MITTAL
Non-Executive - Independent DirectorMrs.RAMA BIJAPURKAR
Non-Executive - Independent DirectorSMKrishnan
Vice President (Finance) & Company Secretary & Compliance OfficerAwards & Recognition
6 Awards- Named among Forbes Asia's 'Fab 50' Companies (2024)
- Included in Dow Jones Sustainability Emerging Markets Index (2024)
- Recipient of the FICCI Healthcare Excellence Award (2023)
- Ranked among India's Most Trusted Healthcare Brands (2024, TRA Research)
- Apollo 24/7 awarded 'Best Digital Health Platform' by ET Healthworld (2024)
- Consistently rated among top hospitals in South Asia by Newsweek (2023, 2024)
Market Information
Company Timeline
41+ Years of Excellence | 8 Major Milestones
Apollo Hospitals founded by Dr. Prathap C. Reddy; first hospital opens in Chennai
Apollo becomes the first Indian hospital group to be listed on Indian stock exchanges
Launch of Apollo Pharmacy, marking entry into organized pharmacy retail
Pioneers large-scale telemedicine services, expanding reach across India
Launch of Apollo 24/7, flagship digital healthcare and telemedicine platform
Crosses 10,000 pharmacy outlets milestone
Bags major accreditations, including JCI and NABH for multiple flagship hospitals
Expands oncology care network and strengthens digital health ecosystem
The Next Evolution
Contact Information
Registered Office
No.19, Bishop Gardens, Raja Annamalaipuram
Tel: 044-28290956 / 28296117 / 28293896,
Fax: 044-28290956,
Email: investor.relations@apollohospitals.com
Website: apollohospitals.com
Registrars
Integrated Registry Management Services Pvt. Ltd (Integrated Enterprises (India) Ltd)
Tel: 044 - 28140801
Email: corpserv@integratedindia.in
Corporate Actions
17| Purpose | Ex Date | Record Date | BC Start | BC End |
|---|---|---|---|---|
Final Dividend ₹10 per share | 14 Aug 2026 Friday | 14 Aug 2026 Friday | - | - |
Interim Dividend ₹10 per share | 16 Feb 2026 Monday | 16 Feb 2026 Monday | - | - |
Final Dividend ₹10 per share | 19 Aug 2025 Tuesday | 19 Aug 2025 Tuesday | - | - |
Interim Dividend ₹9 per share | 14 Feb 2025 Friday | 15 Feb 2025 Saturday | - | - |
Final Dividend ₹10 per share | 16 Aug 2024 Friday | 17 Aug 2024 Saturday | - | - |
Interim Dividend ₹6 per share | 20 Feb 2024 Tuesday | 20 Feb 2024 Tuesday | - | - |
Final Dividend ₹9 per share | 18 Aug 2023 Friday | 19 Aug 2023 Saturday | - | - |
Interim Dividend ₹6 per share | 24 Feb 2023 Friday | 24 Feb 2023 Friday | - | - |
Dividend ₹11.75 per share | 18 Aug 2022 Thursday | - | 20 Aug 2022 Saturday | 25 Aug 2022 Thursday |
Dividend ₹3 per share | 18 Aug 2021 Wednesday | - | 21 Aug 2021 Saturday | 31 Aug 2021 Tuesday |
Final Dividend ₹2.75 per share | 17 Sep 2020 Thursday | - | 19 Sep 2020 Saturday | 25 Sep 2020 Friday |
Interim Dividend ₹3.25 per share | 25 Feb 2020 Tuesday | 26 Feb 2020 Wednesday | - | - |
Dividend ₹6 per share | 12 Sep 2019 Thursday | - | 14 Sep 2019 Saturday | 27 Sep 2019 Friday |
Dividend ₹5 per share | 12 Sep 2018 Wednesday | - | 15 Sep 2018 Saturday | 27 Sep 2018 Thursday |
Dividend ₹6 per share | 07 Sep 2017 Thursday | - | 09 Sep 2017 Saturday | 20 Sep 2017 Wednesday |
Interim Dividend ₹6 per share | 22 Mar 2016 Tuesday | 23 Mar 2016 Wednesday | - | - |
Dividend ₹5.75 per share | 30 Jul 2015 Thursday | - | 01 Aug 2015 Saturday | 11 Aug 2015 Tuesday |
₹1,25,553 Cr.
₹8,763
₹9,050 / 6,697
60.08
₹693.71
12.59
₹145.34
₹5.00
0.23 %
Manage Ratio
FINANCIALS
| Annual Results | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income | - | - | - | 9,649 | 11,274 | 10,605 | 14,741 | 16,703 | 19,166 | 21,994 | 25,420 | 26,630 |
| Expenses | - | - | - | 9,276 | 10,812 | 10,445 | 13,457 | 15,559 | 17,805 | 19,988 | 22,785 | 23,779 |
| Profit | - | - | - | 200 | 432 | 137 | 1,108 | 845 | 935 | 1,505 | 2,003 | 2,172 |
| Tax | - | - | - | 173 | 225 | 85 | 477 | 256 | 446 | 534 | 658 | 705 |
| EPS | - | - | - | 17 | 33 | 11 | 73 | 57 | 63 | 101 | 135 | 40.39 |
| Ratios | - |
Cash Flow
Consolidated Figures in Rs. Crores
| Annual Balance Sheet | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | - |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | - | - | - | 9,183 | 11,339 | 11,417 | 13,214 | 14,428 | 16,753 | 20,657 | 22,197 | - |
| Equity And Liabilities | - | - | - | 9,183 | 11,339 | 11,417 | 13,214 | 14,428 | 16,753 | 20,657 | 22,197 | - |
Shareholding Pattern
Numbers in Percentages
| Quarterly SHP Announcement Date | Mar 2016 12 Apr '16 | Mar 2017 31 Mar '17 | Mar 2018 31 Mar '18 | Mar 2019 08 Apr '19 | Mar 2020 11 May '20 | Mar 2021 19 Apr '21 | Mar 2022 07 Apr '22 | Mar 2023 20 May '23 | Mar 2024 08 Apr '24 | Mar 2025 07 May '25 | Mar 2026 31 Mar '26 | - |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Goverments | - | - | - | 0.23% | 0.23% | 0.23% | 0.23% | 0.23% | 0.23% | 0.23% | - | - |
| Promoter And Promoter Group | - | - | - | 34.40% | 30.81% | 29.82% | 29.33% | 29.33% | 29.33% | 29.34% | - | - |
| Non Institutions | - | - | - | 8.20% | 7.25% | 6.20% | 6.70% | 5.71% | 5.26% | 5.41% | - | - |
| FII | - | - | - | - | - | - | - | 46.96% | 45.63% | 42.74% | - | - |
| DII | - | - | - | - | - | - | - | 17.76% | 19.55% | 22.29% | - | - |
| Total | - | - | - | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | - | - |
Apollo Hospitals Enterprise Ltd
Apollo Hospitals Enterprise Ltd
Apollo Hospitals Enterprise Ltd is India's leading integrated healthcare provider, established in 1983 and headquartered in Chennai. The company operates a vast network of over 70 hospitals, 400+ clinics, 4,000+ pharmacies, as well as diagnostic centers across the country, addressing diverse healthcare needs from primary to tertiary care. Apollo offers specialized services in cardiology, cancer care, orthopedics, neurology, and transplants, with centers of excellence dedicated to complex treatments and surgeries.
Leveraging advanced medical technology, strong clinical expertise, and a robust digital healthcare ecosystem, Apollo Hospitals continually invests in innovation through its telemedicine network, digital health platforms, and healthcare education initiatives. Its vertically integrated model enables cross-referral among its facilities, driving synergy and accessibility within one of India's largest healthcare infrastructures.
Apollo Hospitals earns revenue through a mix of patient care services, pharmacy retail, diagnostics, preventive health programs, and digital health solutions. Core income streams arise from inpatient and outpatient services, major surgical procedures, specialty medicine, and allied services including radiology and pathology. Apollo Pharmacy, the branded retail pharmacy chain, is a significant contributor, with rapid expansion and leadership in organized pharmacy retail.
Strategically, Apollo emphasizes network expansion into tier-II and tier-III cities, acquisition of specialty hospitals, and the development of technology-driven healthcare delivery such as telehealth and app-driven consultation. Growth vectors include value-driven health packages, insurance partnerships, digital health services like Apollo 24/7, and a focus on high-value, complex treatments, enabling recurring engagement and scale across India.
Named among Forbes Asia's 'Fab 50' Companies (2024)
Included in Dow Jones Sustainability Emerging Markets Index (2024)
Recipient of the FICCI Healthcare Excellence Award (2023)
Ranked among India's Most Trusted Healthcare Brands (2024, TRA Research)
Apollo 24/7 awarded 'Best Digital Health Platform' by ET Healthworld (2024)
Consistently rated among top hospitals in South Asia by Newsweek (2023, 2024)
Apollo Hospitals founded by Dr. Prathap C. Reddy; first hospital opens in Chennai
Apollo becomes the first Indian hospital group to be listed on Indian stock exchanges
Launch of Apollo Pharmacy, marking entry into organized pharmacy retail
Pioneers large-scale telemedicine services, expanding reach across India
Launch of Apollo 24/7, flagship digital healthcare and telemedicine platform
Crosses 10,000 pharmacy outlets milestone
Bags major accreditations, including JCI and NABH for multiple flagship hospitals
Expands oncology care network and strengthens digital health ecosystem
Peer Comparison
| S.No. | Company Name | CMP (₹) | Market Cap (₹ Cr) | Div Yld (%) | NP Qtr (₹ Cr) | Qtr Profit Var (%) | Sales Qtr (₹ Cr) | Qtr Sales Var (%) | ROCE (%) | ROE (%) | Book Value (₹) | EPS TTM (₹) | TTMPE Ratio (₹) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Not Found Data | |||||||||||||
Coming Soon
Heatmap View
Premium Feature| Company | CMP (₹) | MCap (₹ Cr) | EPS TTM (₹) | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Not Found Data | |||||||||||||
Financial Ratios
Premium Feature| Company Name | P/E (TTM) | EPS (₹) | D/E | NPM | GPM | ROE (%) | ROCE (%) | P/B | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Not Found Data | |||||||||||||
Coming Soon